EUVIMEDEUVIMED entdecken
Crossref

Differentiating and Quantifying Two Different Amorphous Phases of a Drug Substance in Tablet Formulation by 15 N Solid-State NMR: Derisking the Drug’s Chemical Liability

Ales Medek iD, Mark Strohmeier, Andrew Schuchart, Courtney K Maguire, Lori Ferris

Molecular Pharmaceutics · 06.07.2026 · 23 (7) · 3512-3518

DOI: 10.1021/acs.molpharmaceut.5c00869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 02.06.2026. Verfasst von Ales Medek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Engineering and Materials Science, Vertex Pharmaceuticas, Boston, Massachusetts 02210, United States. Hauptthemen laut MEDLINE: Tablets. Die Arbeit nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TabletsMagnetic Resonance SpectroscopyBulk DrugsExcipientsChemistry, PharmaceuticalCrystallizationDrug CompoundingPotassium

Stichwörter der Autor:innen

amorphous phase in tabletsdifferentiating amorphous phasesquantification of amorphous phasesalt disproportionationsolid-state NMR (SSNMR)

Substanzen

TabletsBulk DrugsExcipientsPotassium

Autor:innen und Institutionen

  • Engineering and Materials Science, Vertex Pharmaceuticas, Boston, Massachusetts 02210, United States.
  • Analytical Development, Vertex Pharmaceuticals, Boston, Massachusetts 02210, United States.
  • Formulation Development, Vertex Pharmaceuticals, Boston, Massachusetts 02210, United States.

ORCID-Profile: Ales Medek

Zitieren

APA

Medek, A., Strohmeier, M., Schuchart, A., Maguire, C. K., & Ferris, L. (2026). Differentiating and Quantifying Two Different Amorphous Phases of a Drug Substance in Tablet Formulation by 15 N Solid-State NMR: Derisking the Drug’s Chemical Liability. Molecular Pharmaceutics, 23(7), 3512-3518. https://doi.org/10.1021/acs.molpharmaceut.5c00869

Vancouver

Medek A, Strohmeier M, Schuchart A, Maguire CK, Ferris L. Differentiating and Quantifying Two Different Amorphous Phases of a Drug Substance in Tablet Formulation by 15 N Solid-State NMR: Derisking the Drug’s Chemical Liability. Molecular Pharmaceutics. 2026;23(7):3512-3518. doi:10.1021/acs.molpharmaceut.5c00869

BibTeX
@article{Medek2026,
  author = {Medek, Ales and Strohmeier, Mark and Schuchart, Andrew and Maguire, Courtney K and Ferris, Lori},
  title = {Differentiating and Quantifying Two Different Amorphous Phases of a Drug Substance in Tablet Formulation by 15 N Solid-State NMR: Derisking the Drug’s Chemical Liability},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {7},
  pages = {3512--3518},
  doi = {10.1021/acs.molpharmaceut.5c00869}
}
Kostenlos starten →